Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Masanori YAMAZAKI"'
Autor:
Satoshi Kubota, Ai Sato, Manami Hosokawa, Yosuke Okubo, Shohei Takayama, Atsuko Kaneko, Yasuho Shimada, Yuki Asano, Yoshihiko Sato, Masanori Yamazaki, Mitsuhisa Komatsu
Publikováno v:
Endocrine Journal, Vol 71, Iss 10, Pp 955-963 (2024)
The effectiveness of a hybrid closed-loop (HCL) system in improving glycemic control is unclear in Japanese individuals. Therefore, we assessed the effect impact of the MiniMed 770G HCL system on glycemic control in this population. This prospective,
Externí odkaz:
https://doaj.org/article/dbc93b665f784ff391ab3740769f3e7a
Autor:
Kouhei Kitajima, Ako Oiwa, Takahiro Miyakoshi, Manami Hosokawa, Mayuka Furihata, Masaaki Takahashi, Shizue Masuki, Hiroshi Nose, Yosuke Okubo, Ai Sato, Masanori Yamazaki, Mitsuhisa Komatsu
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0285762 (2023)
There are few established easy-to-perform exercise protocols with evidence-based effects for individuals with type 2 diabetes (T2D). A unique exercise regimen, interval walking training (IWT), has been reported to be beneficial for improving metaboli
Externí odkaz:
https://doaj.org/article/4ca1bb84ae6648a09d02f534052d9528
Autor:
Miku Obayashi, Yasushi Shibasaki, Toru Koakutsu, Yoshiro Hayashi, Tsuyoshi Shoji, Kazuhisa Hirayama, Masanori Yamazaki, Yasuhiro Takayanagi, Hiroshi Shibata, Masato Nakamura, Hirotoshi Maruo
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Therapy targeting programmed death-1 or programmed death-1 ligand-1 (PD-1/PD-L1) has been developed for various solid malignant tumors, such as melanoma and non-small-cell lung cancer (NSCLC), but this approach has little effect i
Externí odkaz:
https://doaj.org/article/3a77ced20ce54a318496e1ad7c31944c
Publikováno v:
Nuclear Materials and Energy, Vol 25, Iss , Pp 100782- (2020)
Activation analysis of impurities was performed on a test specimen of the reference low-activation vanadium alloy NIFS-HEAT-2 (V-4Cr-4Ti) which has been irradiated in Japan Materials Testing Reactor (JMTR) ~16 years before. Since the radioactive nucl
Externí odkaz:
https://doaj.org/article/00b879520d324366a5d958ad3f97987b
Publikováno v:
Nuclear Materials and Energy, Vol 24, Iss , Pp 100764- (2020)
The effects of displacement damage and helium on the fatigue life of the reduced activation ferritic/martensitic steel, F82H-IEA, were evaluated by fatigue tests at room temperature after neutron irradiation and helium implantation. Those effects at
Externí odkaz:
https://doaj.org/article/cd8bfbc5b28f43aca24e1a31e48a3900
Autor:
Mayu Sakata, Tsuyoshi Syoji, Raisuke Nishiyama, Masami Taniguchi, Masanori Yamazaki, Yukihiro Higashi, Kunihito Suzuki, Takahumi Kawamura, Hajime Yonekawa, Hirotoshi Maruo
Publikováno v:
Case Reports in Gastroenterology, Vol 6, Iss 3, Pp 720-725 (2012)
Focal nodular hyperplasia is a benign liver lesion incidentally discovered with increasing frequency because of the proliferation of imaging studies. Radiographic characterization can diagnose this pathologic lesion and nonoperative therapy is the st
Externí odkaz:
https://doaj.org/article/380f27140e3a4a4087a95712217363cc
Publikováno v:
Case Reports in Gastroenterology, Vol 5, Iss 3, Pp 602-609 (2011)
Adenomyoma of the ileum is a rare condition. A 68-year-old Japanese man presented with nausea and distension of the abdomen. Enhanced computed tomography of his abdomen revealed wall thickening in the ileum and dilation of the proximal small intestin
Externí odkaz:
https://doaj.org/article/44bad743a0f3425ba14ba3b8c23559fa
Publikováno v:
Journal of the Society of Materials Science, Japan. 72:248-253
Autor:
Yohsuke Ohkubo, Masanori Yamazaki, Yasuho Shimada, Satoshi Kubota, Shohei Takayama, Ako Oiwa, Yuta Yamazaki, Hironobu Sasano, Mitsuhisa Komatsu
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 2, p259-264, 6p
Autor:
Ako Oiwa, Dai Hiwatashi, Teiji Takeda, Takahide Miyamoto, Iori Kawata, Masayoshi Koinuma, Masanori Yamazaki, Mitsuhisa Komatsu
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Although adding spironolactone to renin-angiotensin system blockers reduces albuminuria in adults with chronic kidney disease and type 2 diabetes, it increases the risk of hyperkalemia. Objective To assess whether a lower dose of spironolacto